Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials

Fig. 3

Kaplan–Meier event curves for major bleeding and stent thrombosis at 3-year follow-up. Kaplan–Meier event curves for major bleeding and stent thrombosis up to 3-year follow-up showing higher rates of major bleeding in patients with prediabetes and diabetes, and higher rates of definite-or-probable stent thrombosis in patients with diabetes as compared to patients with normoglycemia

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840